2Staelsen S, Gasowski J, Wang J G, et al. Risk of untreated and treated isolated systolic hypertension in the elderly: meta - analysis of out-come trials [ J ]. Lancet,2000,355 ( 9207 ) :865-872.
3Asia Pacific Cohort Studies Collaboration. Systolic blood pressure, di- abetes and the risk of cardiovascular diseases in the Asia - Pacific re- gion[ J ]. J Hyertens ,2007,25 (6) : 1205-1213.
5Dlckstein K. ESC Guidelines for the diagnosis and treatment of acute and chron - ic heart failure 2008 [ J ]. European Heart Joumal,2008, 29:2388-2442.
6Hunt S A,Abraham W T,Chin M N,et al. 2009 Focused update in- corporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults [ J ]. J Am Coil Cardiol,2009, 54(25) :2464.
8Blank R, Lasalle J, Reeves R, et al. Single - pill therapy in the trea tm - ant of concomitant hypertension and dyslipidemia ( the amlodip ine/atorvastatin gemini study) [ J ]. J Chin Hypertens, 2005,7 ( 5 ) : 264-273.
9Sever P S, Pouher N R, Dahoof B, et al. Reduction in cardiovascular e -vents with atorvastatin in 2,532 patients with type 2 diabetes:An- glo - Scandinavian Cardiac Outcomes Trim - lipid - lowering arm ( ASCOT - LLA) [ J ]. Diabetes Care,2005,28 (5) : 1151-1157.
10Jost A, Ranch B, Hochadel M, et al. Beta - blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT - HF study [ J ]. Eur Heart J, 2005,26 ( 24 ) :2689 -2697.
